NDC 51662-1313

SODIUM BICARBONATE 4% (2.4%mEq)

Sodium Bicarbonate 4% (2.4%meq)

SODIUM BICARBONATE 4% (2.4%mEq) is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Sodium Bicarbonate.

Product ID51662-1313_78c422b7-c6b4-3121-e053-2991aa0af891
NDC51662-1313
Product TypeHuman Prescription Drug
Proprietary NameSODIUM BICARBONATE 4% (2.4%mEq)
Generic NameSodium Bicarbonate 4% (2.4%meq)
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-10-21
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameSODIUM BICARBONATE
Active Ingredient Strength0 g/5mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1313-1

5 mL in 1 VIAL, SINGLE-DOSE (51662-1313-1)
Marketing Start Date2018-10-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1313-1 [51662131301]

SODIUM BICARBONATE 4% (2.4%mEq) INJECTION, SOLUTION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-10-21
Marketing End Date2019-12-01
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
SODIUM BICARBONATE.2 g/5mL

OpenFDA Data

SPL SET ID:78c422b7-c6b3-3121-e053-2991aa0af891
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312973

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.